Bio-IS and HSS sign 5-year partnership to deliver Bio-Intervention Disinfection Service to hospitals

NewsGuard 100/100 Score

Bio-Intervention Specialists (Bio-IS) and HSS Inc. (HSS) announced today that their companies have signed a five-year partnership to deliver the Bio-Intervention Disinfection Service to hospitals across the United States.

“We are pleased to partner with Bio-IS to deliver a solution that will help healthcare providers combat these deadly and costly infections.”

Bio-IS has launched the newly EPA-registered Electro-BioCide disinfectant and its Bio-Intervention protocol into the U.S. health care market. HSS is one of the nation's leading healthcare outsourcing companies, having been ranked by Modern Healthcare as the 6th largest in the industry. Together, HSS and Bio-IS will provide hospitals the Bio-Intervention Disinfection Service, a 21st century solution to the challenge of hard-surface disinfection.

Today, most hospitals follow the same approach to hard-surface disinfection as they have for the past 35 years: a housekeeper, using a spray bottle and rag. Through the power of Mother Nature and mutation, this legacy approach is no longer effective against the superbugs of the 21st century.

Utilizing the newly EPA-registered Electro-BioCide disinfectant, the companies have certified Bio-Intervention Technicians that use portable electrostatic sprayers to comprehensively disinfect the hard surfaces of hospitals and healthcare facilities using a specific, step-by-step, protocol. This combination of skilled specialists and innovative technology solves the current weak links of hard surface infection control.

Tom Boyer, President and CEO of Bio-IS, said, "We are very excited about this partnership because of the outstanding reputation of HSS and their 90+% customer retention rates. Their commitment to quality is second to none and we are honored to have them as our partner. Both companies are truly committed to saving lives and reducing costs through the Bio-Intervention Disinfection Service."

"Reducing hospital-acquired infections will save lives and reduce costs," said Wayne Schell, CEO, HSS. "We are pleased to partner with Bio-IS to deliver a solution that will help healthcare providers combat these deadly and costly infections."

This service is currently available in 35 states. The companies expect complete national coverage in early 2011. Teams are available for either emergent or continuous on-site deployment.

SOURCE Bio-Intervention Specialists and HSS Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI technologies can accurately identify cases of healthcare-associated infections